A cardiomyocyte-specific Lmna-deprived mouse model exhibited improved cardiac function, and abrogated cardiac arrhythmia and fibrosis formation, after treatment with the pan inhibitor of BET bromodomain protein JQ1 (Auguste et al., 2020). This evidence concerns the gene LMNA and cardiac rhythm disease.